Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Calliditas Therapeutics
CALTCurrent price
38.19 USD
+0.05 USD (+0.13%)
Last closed
38.15 USD
Company
www.calliditas.se
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
1 049 649 664 USD
Yield for 12 month
+114.55 %
1Y
3Y
5Y
10Y
15Y
CALT
Calliditas Therapeutics AB (publ), a commercial-stage bio-pharmaceutical company, focused on identifying, developing, and commercializing novel treatments in orphan indications with an initial focus on renal and hepatic diseases with significant unmet medical needs in the United States, Europe, and Asia. It offers Nefecon (TARPEYO/Kinpeygo), an oral formulation of budesonide to reduce the loss of kidney function in adults with immunoglobulin A nephropathy. The company's lead compound is Setanaxib, a NOX inhibitor that is in Phase 2b clinical trial for the treatment of primary biliary cholangitis; and in Phase 2 clinical trial for the treatment of squamous cell carcinoma of the head and neck cancer and idiopathic pulmonary fibrosis, as well as for solid tumors and Alport Syndrome. Calliditas Therapeutics AB (publ) was incorporated in 2004 and is headquartered in Stockholm, Sweden. Address: Kungsbron 1, D5, Stockholm, Sweden, 111 22
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
35.5 USDP/E ratio
–Dividend Yield
–Current Year
+112 460 409 USD
Last Year
+74 813 985 USD
Current Quarter
+42 077 421 USD
Last Quarter
+42 077 421 USD
Current Year
+105 280 073 USD
Last Year
+73 397 523 USD
Current Quarter
+39 999 553 USD
Last Quarter
+39 999 553 USD
Key Figures CALT
1 year
3 years
5 years
10 years
EBITDA
-409 569 984 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-14.9 %
PEG Ratio
–
Return On Equity TTM
-147.93 %
Wall Street Target Price
35.5 USD
Revenue TTM
1 311 016 960 USD
Book Value
2.24 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
54.4 %
Dividend Yield
–
Gross Profit TTM
787 678 000 USD
Earnings per share
-1.85 USD
Diluted Eps TTM
-1.85 USD
Most Recent Quarter
I 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-40.03 %
Dividend Analytics CALT
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History CALT
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation CALT
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
18.3824
Enterprise Value Revenue
0.4267
Price Sales TTM
0.4522
Enterprise Value EBITDA
-1.3804
Price Book MRQ
16.341
Financials CALT
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators CALT
For 52 weeks
15.25 USD
41.9 USD
50 Day MA
34.95 USD
Shares Short Prior Month
8 161
200 Day MA
24.19 USD
Short Ratio
0.31
Shares Short
9 263
Short Percent
0.27 %
BeatStart